泽璟制药：注射用ZGGS18与注射用ZG005及化疗联用获得药物临床试验批准

Group 1 - The company has received approval from the National Medical Products Administration for the clinical trial of ZGGS18 and ZG005 in combination with chemotherapy for advanced solid tumors [1]